{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F72f58661-a975-47ce-81b5-db2e9bbbfc61","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"335: Garnering Investor Recognition  |  Josh Blacher, CFO of Therapix Biosciences\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/72f58661-a975-47ce-81b5-db2e9bbbfc61\"></iframe>","title":"335: Garnering Investor Recognition  |  Josh Blacher, CFO of Therapix Biosciences","description":"","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/490ad3ba-b04d-42c2-9ec2-f9cc2314e9f7/NkEdHG_HbUSc9qkmrRCA4j14.jpg"}